ClinicalTrials.gg
Not yet recruitingNCT07529353EXCAP-hEATUpdated Aug 17, 2026

Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .

An interventional study of EXCAP Exercise Program and 10-Hour Healthy Eating Timeframe (hEAT) in Breast Cancer and Cancer Related Fatigue, sponsored by University of Rochester. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by University of Rochester · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 16 studies in Breast Neoplasms by University of Rochester — 5 open to participants now, 5 under way, none of them phase 3. Breast Neoplasms · University of Rochester.

Planned enrollment
10th of 14
20 · median 34
Started
2026
with 1 other
No phase
7 of 16
3 open now
Registered
14th of 16
by date

Among the 16 studies in Breast Neoplasms by University of Rochester, this one is the 10th largest by planned enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2026, is one of 7 with no phase, and was the 14th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

5 of the 16 studies in Breast Neoplasms by University of Rochester are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Breast Neoplasms by University of Rochester, or all of them as a file.
02

Study summary

This study evaluates the feasibility and preliminary effects of a home based exercise and activity program for individuals with cancer. Participants will engage in a structured intervention designed to support physical activity and symptom management. The study will assess changes in patient reported outcomes, functional measures, and overall adherence to the program. Findings will help determine whether this approach is practical and potentially beneficial for improving health related outcomes in this population.

03

Conditions studied

  • Breast Cancer
  • Cancer Related Fatigue

Browse trials for

Keywords

  • Breast Cancer Survivorship
  • Home Based Exercise
  • Fatigue Management
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be aged 18 years or older
  • Must have a confirmed diagnosis of breast cancer (stage I-IIIC)
  • Must have completed chemotherapy, surgery, and/or radiation for cancer at least 2 - 120 months prior to enrolling,
  • Must be prescribed adjuvant endocrine therapy,
  • Must have a baseline level of fatigue, as determined by reporting a score of 4 or higher on the Symptom Inventory
  • Must have a greater than or equal to 25 kg per meter squared
  • Must have the ability to ambulate independently
  • Must be willing and able to participate in home-based exercise and eating timeframe intervention
  • Must have the ability to read and understand the English language,

Exclusion criteria

Exclusion Criteria:

  • Must not have or recurrent breast cancer
  • Must not be currently receiving chemotherapy or radiation therapy
  • Must not have a medical condition that would preclude safe participation in intervention or study procedures
  • Must not be pregnant, or planning to become pregnant during the study period
  • Must not be in the active or maintenance stage of exercise behavior as assessed by the Exercise Stages of Change Short Form,
  • Must not have any condition that in the opinion of the investigator would interfere with participation or safety
  • Must not be currently using, or plan to initiate use of prescription or over-the-counter weight-loss medications
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Adjuvant and neoadjuvant

Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumor. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    EXCAP-hEAT Intervention

    Participants will complete a 6-week home-based combined lifestyle intervention consisting of a structured exercise program (EXCAP) and a self-selected 10-hour daily healthy eating timeframe. The intervention includes aerobic walking, progressive resistance band training, and daily tracking of eating timeframes and physical activity.

    Behavioral: EXCAP Exercise Program · Behavioral: 10-Hour Healthy Eating Timeframe (hEAT)

Interventions

  • BehavioralEXCAP Exercise Program

    Home-based walking prescription with progressive 5% weekly step increase and resistance band training performed at least twice per week over 6 weeks.

  • Behavioral10-Hour Healthy Eating Timeframe (hEAT)

    Participants will self-select and maintain a daily eating window of 10 hours or less for 6 weeks, with timing of first and last meals recorded daily.

06

What researchers measure

Primary outcomes

  1. Proportion of Participants Meeting Pre-Specified Adherence Criteria

    Percentage of participants who meet all three adherence criteria during the 6-week intervention: Maintain a ≤10-hour eating timeframe on at least 50 percent of intervention days (21 of 42 days) Complete resistance band exercises at least 12 total sessions during the 6-week period Increase average weekly step count by at least 20 percent from baseline to Week 6

    Time frame: Baseline to Day 42

Secondary outcomes

  1. Mean Change in Brief Fatigue Inventory Total Score

    Mean difference in total BFI score from baseline (Day 0) to post-intervention (Day 42). Higher scores indicate greater fatigue.

    Time frame: Baseline to Day 42

  2. Mean Change in Multidimensional Fatigue Symptom Inventory Total Score

    Mean difference in total MFSI score from baseline (Day 0) to post-intervention (Day 42). Higher scores indicate greater fatigue burden.

    Time frame: Baseline to Day 42

  3. Mean Change in Body Mass Index

    Mean difference in BMI (kg/m²) measured at baseline and at Day 42.

    Time frame: Baseline to Day 42

  4. Mean Change in 30-Second Bicep Curl Test Repetitions

    Mean difference in total number of completed bicep curl repetitions within 30 seconds from baseline to Day 42.

    Time frame: Baseline to Day 42

  5. Mean Change in 30-Second Chair Stand Test Repetitions

    Mean difference in total number of completed chair stands within 30 seconds from baseline to Day 42.

    Time frame: Baseline to Day 42

  6. Mean Change in Estimated Submaximal VO2

    Mean difference in estimated VO2submax (mL/kg/min) obtained from treadmill testing at baseline and Day 42.

    Time frame: Baseline to Day 42

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 12 months is below that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2026
First posted
Apr 14, 2026
StartEst.
Oct 2026
Primary completionEst.
Oct 2027
CompletionEst.
Oct 2028
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07529353
Responsible party
Lindsey Mattick (Research Assistant Professor - Department of Surgery, University of Rochester) — Principal investigator
First posted
Apr 14, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2028 (estimated)
Last update
Aug 17, 2026

Study contacts

Lindsey Mattick, PhD
Contact
Lindsey_Mattick@urmc.rochester.edu
5852740473
Lindsey Mattick, PhD
principal investigator · University of Rochester

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion